COSTEM — The 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), Hybrid Congress

We are happy to announce the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), Hybrid Congress which will take place October 27-30, 2022 in Berlin, Germany, and online. We are planning to hold the congress as a hybrid edition (with both face-to-face and virtual components). COSTEM is moving to become an annual event as we feel it is important to build a platform for our community to interact with each other and to share our scientific research, clinical experience, and on-going developments in our field. COSTEM encourages active participation in debate discussions, and challenges global experts to promote their positions on a wide range of burning issues – providing clinicians the opportunity to share, express and compare experiences to establish and advance effective and reliable patient treatments. The 7th COSTEM Congress will continue to push the envelope and be a progressive, compelling, and informative conference. As in the past, COSTEM continues to serve as a unique platform, where the most compelling and controversial topics facing clinicians in these fields are presented in a fascinating and exciting debate forum.

Topics: • CAR-T cell therapy • Haploidentical stem cell transplantation • Cellular therapy • Transplantation • GVHD prevention and treatment • Cord blood transplantation • Mesenchymal stem cell • Acute leukemia • Myelodysplastic syndrome • Multiple myeloma • Hodgkin and Non-Hodgkin lymphoma • Myeloproliferative neoplasm • Virus specific T Cell therapy • NK Cell therapy • Microbiome • Genome editing and gene therapy • Bone marrow failure syndrome • Bi-specific antibodies • CMV infection • Toxicity post transplantation (VOD, TMA etc)